{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T10:25:12Z","timestamp":1793874312382,"version":"4.6.1"},"reference-count":159,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.bbagen.2026.131009","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:17:03Z","timestamp":1790291823000},"page":"131009","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rapamycin across biology and medicine: From molecular mechanisms to clinical and translational frontiers"],"prefix":"10.1016","volume":"1870","author":[{"given":"Lyvia Neves Rebello Alves","family":"Nolasco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eldam\u00e1ria de Vargas Wolfgramm","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel Silva dos Reis","family":"Trabach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9bora Dummer","family":"Meira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I\u00fari Drumond","family":"Louro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagen.2026.131009_bb0005","series-title":"Stanley\u2019s Dream: The Medical Expedition to Easter Island","author":"Duffin","year":"2019"},{"issue":"13","key":"10.1016\/j.bbagen.2026.131009_bb0010","doi-asserted-by":"crossref","DOI":"10.1091\/mbc.E22-08-0377","article-title":"The origin story of rapamycin: systemic bias in biomedical research and cold war politics","volume":"33","author":"Powers","year":"2022","journal-title":"Mol. Biol. Cell"},{"issue":"3 Suppl","key":"10.1016\/j.bbagen.2026.131009_bb0015","doi-asserted-by":"crossref","first-page":"7S","DOI":"10.1016\/S0041-1345(03)00211-2","article-title":"Sirolimus: its discovery, biological properties, and mechanism of action","volume":"35","author":"Sehgal","year":"2003","journal-title":"Transplant. Proc."},{"issue":"1","key":"10.1016\/j.bbagen.2026.131009_bb0020","article-title":"mTOR signaling networks: mechanistic insights and translational frontiers in disease therapeutics","volume":"10","author":"Zhang","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"10","key":"10.1016\/j.bbagen.2026.131009_bb0025","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1093\/ckj\/sfac116","article-title":"A treasure from a barren island: the discovery of rapamycin","volume":"15","author":"Hobby","year":"2022","journal-title":"Clin. Kidney J."},{"issue":"10","key":"10.1016\/j.bbagen.2026.131009_bb0030","doi-asserted-by":"crossref","first-page":"727","DOI":"10.7164\/antibiotics.28.727","article-title":"Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization","volume":"28","author":"Sehgal","year":"1975","journal-title":"J. Antibiot. (Tokyo)"},{"issue":"10","key":"10.1016\/j.bbagen.2026.131009_bb0035","doi-asserted-by":"crossref","first-page":"721","DOI":"10.7164\/antibiotics.28.721","article-title":"Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle","volume":"28","author":"V\u00e9zina","year":"1975","journal-title":"J. Antibiot. (Tokyo)"},{"issue":"18","key":"10.1016\/j.bbagen.2026.131009_bb0040","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1139\/v78-407","article-title":"The X-ray crystal structure of rapamycin, C51H79NO13","volume":"56","author":"Swindells","year":"1978","journal-title":"Can. J. Chem."},{"issue":"10","key":"10.1016\/j.bbagen.2026.131009_bb0045","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.7164\/antibiotics.37.1231","article-title":"Activity of rapamycin (AY-22,989) against transplanted tumors","volume":"37","author":"Eng","year":"1984","journal-title":"J. Antibiot. (Tokyo)"},{"issue":"6244","key":"10.1016\/j.bbagen.2026.131009_bb0050","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/341758a0","article-title":"A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase","volume":"341","author":"Harding","year":"1989","journal-title":"Nature"},{"issue":"34","key":"10.1016\/j.bbagen.2026.131009_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/S0021-9258(17)45319-1","article-title":"The cytosolic-binding protein for the immunosuppressant FK-506 is both a ubiquitous and highly conserved peptidyl-prolyl cis-trans isomerase","volume":"265","author":"Siekierka","year":"1990","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bbagen.2026.131009_bb0060","first-page":"1718","article-title":"Rapamycin sensitivity in Saccharomyces cerevisiae is mediated by a peptidyl-prolyl cis-trans isomerase related to human FK506-binding protein","volume":"11","author":"Koltin","year":"1991","journal-title":"Mol. Cell. Biol."},{"issue":"23","key":"10.1016\/j.bbagen.2026.131009_bb0065","doi-asserted-by":"crossref","first-page":"9231","DOI":"10.1073\/pnas.87.23.9231","article-title":"Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin","volume":"87","author":"Bierer","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5022","key":"10.1016\/j.bbagen.2026.131009_bb0070","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1126\/science.1715094","article-title":"Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast","volume":"253","author":"Heitman","year":"1991","journal-title":"Science"},{"issue":"6483","key":"10.1016\/j.bbagen.2026.131009_bb0075","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/369756a0","article-title":"A mammalian protein targeted by G1-arresting rapamycin-receptor complex","volume":"369","author":"Brown","year":"1994","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbagen.2026.131009_bb0080","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0092-8674(94)90570-3","article-title":"RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs","volume":"78","author":"Sabatini","year":"1994","journal-title":"Cell"},{"issue":"26","key":"10.1016\/j.bbagen.2026.131009_bb0085","doi-asserted-by":"crossref","first-page":"12574","DOI":"10.1073\/pnas.91.26.12574","article-title":"RAPT1, a mammalian homolog of yeast Tor, interacts with the FKBP12\/rapamycin complex","volume":"91","author":"Chiu","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.bbagen.2026.131009_bb0090","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1074\/jbc.270.2.815","article-title":"Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells","volume":"270","author":"Sabers","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2026.131009_bb0095","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.gene.2018.12.046","article-title":"Halcyon days of TOR: reflections on the multiple independent discovery of the yeast and mammalian TOR proteins","volume":"692","author":"Livi","year":"2019","journal-title":"Gene"},{"issue":"6","key":"10.1016\/j.bbagen.2026.131009_bb0100","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1007\/BF00166931","article-title":"Effect of amino acids on rapamycin biosynthesis by Streptomyces hygroscopicus","volume":"43","author":"Cheng","year":"1995","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"6","key":"10.1016\/j.bbagen.2026.131009_bb0105","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/BF01573954","article-title":"Carbon source nutrition of rapamycin biosynthesis in Streptomyces hygroscopicus","volume":"14","author":"Kojima","year":"1995","journal-title":"J. Ind. Microbiol."},{"issue":"7","key":"10.1016\/j.bbagen.2026.131009_bb0110","doi-asserted-by":"crossref","first-page":"657","DOI":"10.7164\/antibiotics.48.657","article-title":"Generation of novel rapamycin structures by microbial manipulations","volume":"48","author":"Nishida","year":"1995","journal-title":"J. Antibiot. (Tokyo)"},{"issue":"5","key":"10.1016\/j.bbagen.2026.131009_bb0115","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0024-3205(95)02233-3","article-title":"Mechanism of action of the immunosuppressant rapamycin","volume":"58","author":"Dumont","year":"1996","journal-title":"Life Sci."},{"issue":"4\u20135","key":"10.1016\/j.bbagen.2026.131009_bb0120","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s10295-016-1834-7","article-title":"An overview of rapamycin: from discovery to future perspectives","volume":"44","author":"Yoo","year":"2017","journal-title":"J. Ind. Microbiol. Biotechnol."},{"issue":"4","key":"10.1016\/j.bbagen.2026.131009_bb0125","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1007\/s11033-023-08283-x","article-title":"Molecular and therapeutic insights of rapamycin: a multi-faceted drug from Streptomyces hygroscopicus","volume":"50","author":"Ganesh","year":"2023","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.bbagen.2026.131009_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fragi.2025.1628187","article-title":"Rapamycin for longevity: the pros, the cons, and future perspectives","volume":"6","author":"Roark","year":"2025","journal-title":"Front. Aging"},{"issue":"1","key":"10.1016\/j.bbagen.2026.131009_bb0135","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1039\/C7MD00474E","article-title":"Synthesis and biological evaluation of rapamycin-derived, next generation small molecules","volume":"9","author":"Guduru","year":"2018","journal-title":"Medchemcomm"},{"issue":"5","key":"10.1016\/j.bbagen.2026.131009_bb0140","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1007\/s11357-023-00935-x","article-title":"Blazing a trail for the clinical use of rapamycin as a geroprotecTOR","volume":"45","author":"Konopka","year":"2023","journal-title":"Geroscience"},{"key":"10.1016\/j.bbagen.2026.131009_bb0145","series-title":"The Enzymes","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S1874-6047(10)27017-8","article-title":"Chapter 17 - chemistry and pharmacology of rapamycin and its derivatives","volume":"27","author":"Abraham","year":"2010"},{"issue":"7448","key":"10.1016\/j.bbagen.2026.131009_bb0150","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature12122","article-title":"mTOR kinase structure, mechanism and regulation","volume":"497","author":"Yang","year":"2013","journal-title":"Nature"},{"issue":"6268","key":"10.1016\/j.bbagen.2026.131009_bb0155","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1126\/science.aaa3870","article-title":"Architecture of human mTOR complex 1","volume":"351","author":"Aylett","year":"2016","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.bbagen.2026.131009_bb0160","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/j.cell.2022.04.013","article-title":"mTOR substrate phosphorylation in growth control","volume":"185","author":"Battaglioni","year":"2022","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.bbagen.2026.131009_bb0165","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/s41422-018-0029-3","article-title":"Cryo-EM structure of human mTOR complex 2","volume":"28","author":"Chen","year":"2018","journal-title":"Cell Res."},{"issue":"45","key":"10.1016\/j.bbagen.2026.131009_bb0170","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc1251","article-title":"The 3.2-\u00c5 resolution structure of human mTORC2","volume":"6","author":"Scaiola","year":"2020","journal-title":"Sci. Adv."},{"issue":"2","key":"10.1016\/j.bbagen.2026.131009_bb0175","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molcel.2006.03.029","article-title":"Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt\/PKB","volume":"22","author":"Sarbassov","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbagen.2026.131009_bb0180","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3389\/fimmu.2014.00686","article-title":"mTOR links environmental signals to T cell fate decisions","volume":"5","author":"Chapman","year":"2015","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.bbagen.2026.131009_bb0185","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1152\/physrev.00026.2020","article-title":"Regulation and metabolic functions of mTORC1 and mTORC2","volume":"101","author":"Szwed","year":"2021","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbagen.2026.131009_bb0190","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13578-020-00396-1","article-title":"MTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges","volume":"10","author":"Zou","year":"2020","journal-title":"Cell Biosci."},{"issue":"8","key":"10.1016\/j.bbagen.2026.131009_bb0195","article-title":"PI3K\/AKT\/mTOR axis in cancer: from pathogenesis to treatment","volume":"6","author":"Jiang","year":"2025","journal-title":"MedComm (2020)."},{"issue":"1","key":"10.1016\/j.bbagen.2026.131009_bb0200","first-page":"195","article-title":"Rapamycin regulates the balance between cardiomyocyte apoptosis and autophagy in chronic heart failure by inhibiting mTOR signaling","volume":"45","author":"Gao","year":"2020","journal-title":"Int. J. Mol. Med."},{"issue":"9","key":"10.1016\/j.bbagen.2026.131009_bb0205","article-title":"The long scientific journey of Sirolimus (rapamycin): from the soil of Easter Island (Rapa Nui) to applied research and clinical trials on \u03b2-thalassemia and other hemoglobinopathies","volume":"12","author":"Gambari","year":"2023","journal-title":"Biol.-Basel"},{"issue":"6","key":"10.1016\/j.bbagen.2026.131009_bb0210","doi-asserted-by":"crossref","first-page":"7770","DOI":"10.3390\/molecules19067770","article-title":"Selective substitution of 31\/42-OH in rapamycin guided by an in situ IR technique","volume":"19","author":"Cao","year":"2014","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.bbagen.2026.131009_bb0215","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bbagen.2026.131009_bb0220","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3390\/ijms22010173","article-title":"PI3K\/AKT\/mTOR signaling pathway in breast cancer: from molecular landscape to clinical aspects","volume":"22","author":"Miricescu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbagen.2026.131009_bb0225","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41392-023-01608-z","article-title":"Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease","volume":"8","author":"Panwar","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"2","key":"10.1016\/j.bbagen.2026.131009_bb0230","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.jsb.2010.01.002","article-title":"Insights into the domain and repeat architecture of target of rapamycin","volume":"170","author":"Knutson","year":"2010","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.bbagen.2026.131009_bb0235","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11016","article-title":"Tor forms a dimer through an N-terminal helical solenoid with a complex topology","volume":"7","author":"Bareti\u0107","year":"2016","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.bbagen.2026.131009_bb0240","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1007\/s13238-016-0346-6","article-title":"4.4 \u00c5 resolution Cryo-EM structure of human mTOR complex 1","volume":"7","author":"Yang","year":"2016","journal-title":"Protein Cell"},{"issue":"5272","key":"10.1016\/j.bbagen.2026.131009_bb0245","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1126\/science.273.5272.239","article-title":"Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP","volume":"273","author":"Choi","year":"1996","journal-title":"Science"},{"issue":"21","key":"10.1016\/j.bbagen.2026.131009_bb0250","doi-asserted-by":"crossref","first-page":"20558","DOI":"10.1074\/jbc.M501116200","article-title":"The solution structure of the FATC domain of the protein kinase target of rapamycin suggests a role for redox-dependent structural and cellular stability","volume":"280","author":"Dames","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bbagen.2026.131009_bb0255","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41580-019-0199-y","article-title":"mTOR at the nexus of nutrition, growth, ageing and disease","volume":"21","author":"Liu","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1\u20132","key":"10.1016\/j.bbagen.2026.131009_bb0260","first-page":"109","article-title":"mTORC1, the maestro of cell metabolism and growth","volume":"39","author":"He","year":"2025","journal-title":"Genes Dev."},{"issue":"2","key":"10.1016\/j.bbagen.2026.131009_bb0265","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0092-8674(02)00833-4","article-title":"Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action","volume":"110","author":"Hara","year":"2002","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.bbagen.2026.131009_bb0270","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.cell.2009.03.046","article-title":"DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival","volume":"137","author":"Peterson","year":"2009","journal-title":"Cell"},{"issue":"14","key":"10.1016\/j.bbagen.2026.131009_bb0275","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.cub.2004.06.054","article-title":"Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton","volume":"14","author":"Sarbassov","year":"2004","journal-title":"Curr. Biol."},{"issue":"1","key":"10.1016\/j.bbagen.2026.131009_bb0280","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cell.2006.08.033","article-title":"SIN1\/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity","volume":"127","author":"Jacinto","year":"2006","journal-title":"Cell"},{"issue":"20","key":"10.1016\/j.bbagen.2026.131009_bb0285","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1101\/gad.1461206","article-title":"Identification of Sin1 as an essential TORC2 component required for complex formation and kinase activity","volume":"20","author":"Yang","year":"2006","journal-title":"Genes Dev."},{"issue":"6","key":"10.1016\/j.bbagen.2026.131009_bb0290","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.devcel.2022.02.024","article-title":"The central moTOR of metabolism","volume":"57","author":"Simcox","year":"2022","journal-title":"Dev. Cell"},{"issue":"7","key":"10.1016\/j.bbagen.2026.131009_bb0295","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28073157","article-title":"Targeting mTOR for anti-aging and anti-cancer therapy","volume":"28","author":"Fu","year":"2023","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.bbagen.2026.131009_bb0300","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bbagen.2026.131009_bb0305","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1042\/BCJ20220325","article-title":"The mTORC2 signaling network: targets and cross-talks","volume":"481","author":"Ragupathi","year":"2024","journal-title":"Biochem. J."},{"issue":"36","key":"10.1016\/j.bbagen.2026.131009_bb0310","doi-asserted-by":"crossref","first-page":"25227","DOI":"10.1074\/jbc.M114.554881","article-title":"Akt-dependent activation of mTORC1 complex involves phosphorylation of mTOR (mammalian target of rapamycin) by I\u03baB kinase \u03b1 (IKK\u03b1)","volume":"289","author":"Dan","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bbagen.2026.131009_bb0315","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.tem.2019.09.005","article-title":"Growth factor-dependent and -independent activation of mTORC2","volume":"31","author":"Knudsen","year":"2020","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.bbagen.2026.131009_bb0320","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.semcdb.2014.09.011","article-title":"Growing knowledge of the mTOR signaling network","volume":"36","author":"Huang","year":"2014","journal-title":"Semin. Cell Dev. Biol."},{"issue":"8","key":"10.1016\/j.bbagen.2026.131009_bb0325","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/ncb1753","article-title":"Regulation of TORC1 by Rag GTPases in nutrient response","volume":"10","author":"Kim","year":"2008","journal-title":"Nat. Cell Biol."},{"issue":"5882","key":"10.1016\/j.bbagen.2026.131009_bb0330","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1126\/science.1157535","article-title":"The rag GTPases bind raptor and mediate amino acid signaling to mTORC1","volume":"320","author":"Sancak","year":"2008","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.bbagen.2026.131009_bb0335","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.cub.2005.02.053","article-title":"Rheb binds and regulates the mTOR kinase","volume":"15","author":"Long","year":"2005","journal-title":"Curr. Biol."},{"issue":"6","key":"10.1016\/j.bbagen.2026.131009_bb0340","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.cell.2012.07.032","article-title":"Ragulator is a GEF for the rag GTPases that signal amino acid levels to mTORC1","volume":"150","author":"Bar-Peled","year":"2012","journal-title":"Cell"},{"issue":"6136","key":"10.1016\/j.bbagen.2026.131009_bb0345","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1126\/science.1232044","article-title":"A tumor suppressor complex with GAP activity for the rag GTPases that signal amino acid sufficiency to mTORC1","volume":"340","author":"Bar-Peled","year":"2013","journal-title":"Science"},{"issue":"7919","key":"10.1016\/j.bbagen.2026.131009_bb0350","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/s41586-022-04939-z","article-title":"Structure of the nutrient-sensing hub GATOR2","volume":"607","author":"Valenstein","year":"2022","journal-title":"Nature"},{"issue":"7645","key":"10.1016\/j.bbagen.2026.131009_bb0355","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/nature21423","article-title":"KICSTOR recruits GATOR1 to the lysosome and is necessary for nutrients to regulate mTORC1","volume":"543","author":"Wolfson","year":"2017","journal-title":"Nature"},{"issue":"6268","key":"10.1016\/j.bbagen.2026.131009_bb0360","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1126\/science.aab2674","article-title":"Sestrin2 is a leucine sensor for the mTORC1 pathway","volume":"351","author":"Wolfson","year":"2016","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bbagen.2026.131009_bb0365","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cell.2016.02.035","article-title":"The CASTOR proteins are arginine sensors for the mTORC1 pathway","volume":"165","author":"Chantranupong","year":"2016","journal-title":"Cell"},{"issue":"6218","key":"10.1016\/j.bbagen.2026.131009_bb0370","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1126\/science.1257132","article-title":"Metabolism. Lysosomal amino acid transporter SLC38A9 signals arginine sufficiency to mTORC1","volume":"347","author":"Wang","year":"2015","journal-title":"Science"},{"issue":"7544","key":"10.1016\/j.bbagen.2026.131009_bb0375","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nature14107","article-title":"SLC38A9 is a component of the lysosomal amino acid sensing machinery that controls mTORC1","volume":"519","author":"Rebsamen","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bbagen.2026.131009_bb0380","doi-asserted-by":"crossref","DOI":"10.12703\/r\/10-50","article-title":"Regulation of mTORC1 activity by the Golgi apparatus","volume":"10","author":"Makhoul","year":"2021","journal-title":"Fac. Rev."},{"issue":"4","key":"10.1016\/j.bbagen.2026.131009_bb0385","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.cmet.2016.03.013","article-title":"Amino acid sensing by mTORC1: intracellular transporters mark the spot","volume":"23","author":"Goberdhan","year":"2016","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.bbagen.2026.131009_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109031","article-title":"Leucine-sensing mechanism of leucyl-tRNA synthetase 1 for mTORC1 activation","volume":"35","author":"Kim","year":"2021","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.bbagen.2026.131009_bb0395","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.cell.2012.02.044","article-title":"Leucyl-tRNA synthetase is an intracellular leucine sensor for the mTORC1-signaling pathway","volume":"149","author":"Han","year":"2012","journal-title":"Cell"},{"issue":"6364","key":"10.1016\/j.bbagen.2026.131009_bb0400","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1126\/science.aao3265","article-title":"SAMTOR is an S-adenosylmethionine sensor for the mTORC1 pathway","volume":"358","author":"Gu","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.bbagen.2026.131009_bb0405","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.semcdb.2020.02.007","article-title":"Spatial regulation of mTORC1 signalling: beyond the Rag GTPases","volume":"107","author":"Carroll","year":"2020","journal-title":"Semin. Cell Dev. Biol."},{"issue":"11","key":"10.1016\/j.bbagen.2026.131009_bb0410","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1038\/s41556-024-01523-7","article-title":"Spatial and functional separation of mTORC1 signalling in response to different amino acid sources","volume":"26","author":"Fernandes","year":"2024","journal-title":"Nat. Cell Biol."},{"issue":"19","key":"10.1016\/j.bbagen.2026.131009_bb0415","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1002\/1873-3468.12711","article-title":"mTORC1 and mTORC2 as regulators of cell metabolism in immunity","volume":"591","author":"Linke","year":"2017","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.bbagen.2026.131009_bb0420","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-022-00859-7","article-title":"mTORC2: a multifaceted regulator of autophagy","volume":"21","author":"Sun","year":"2023","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.bbagen.2026.131009_bb0425","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.655731","article-title":"The mTOR-autophagy axis and the control of metabolism","volume":"9","author":"Deleyto-Seldas","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"2","key":"10.1016\/j.bbagen.2026.131009_bb0430","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.cell.2019.02.013","article-title":"Mitochondrial permeability uncouples elevated autophagy and lifespan extension","volume":"177","author":"Zhou","year":"2019","journal-title":"Cell"},{"issue":"17","key":"10.1016\/j.bbagen.2026.131009_bb0435","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1038\/onc.2014.164","article-title":"mTORC1 drives HIF-1\u03b1 and VEGF-A signalling via multiple mechanisms involving 4E-BP1, S6K1 and STAT3","volume":"34","author":"Dodd","year":"2015","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.bbagen.2026.131009_bb0440","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/s13046-022-02513-z","article-title":"STAT3\/miR-130b-3p\/MBNL1 feedback loop regulated by mTORC1 signaling promotes angiogenesis and tumor growth","volume":"41","author":"Li","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.bbagen.2026.131009_bb0445","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19082453","article-title":"Role of mTOR signaling in tumor microenvironment: an overview","volume":"19","author":"Conciatori","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.bbagen.2026.131009_bb0450","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135245","article-title":"Endothelial cell mTOR complex-2 regulates sprouting angiogenesis","volume":"10","author":"Farhan","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbagen.2026.131009_bb0455","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fnmol.2011.00051","article-title":"PI3K\/AKT\/mTOR pathway in angiogenesis","volume":"4","author":"Karar","year":"2011","journal-title":"Front. Mol. Neurosci."},{"issue":"5","key":"10.1016\/j.bbagen.2026.131009_bb0460","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.4049\/jimmunol.176.5.2730","article-title":"Prolonged TCR\/CD28 engagement drives IL-2-independent T cell clonal expansion through signaling mediated by the mammalian target of rapamycin","volume":"176","author":"Colombetti","year":"2006","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.bbagen.2026.131009_bb0465","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/leu.2011.56","article-title":"Intracellular reactive oxygen species are essential for PI3K\/Akt\/mTOR-dependent IL-7-mediated viability of T-cell acute lymphoblastic leukemia cells","volume":"25","author":"Silva","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.bbagen.2026.131009_bb0470","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1146\/annurev-immunol-020711-075024","article-title":"Regulation of immune responses by mTOR","volume":"30","author":"Powell","year":"2012","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bbagen.2026.131009_bb0475","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3389\/fimmu.2015.00355","article-title":"IL-15-PI3K-AKT-mTOR: a critical pathway in the life journey of natural killer cells","volume":"6","author":"Ali","year":"2015","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.bbagen.2026.131009_bb0480","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.immuni.2015.08.017","article-title":"The Interleukin-2-mTORc1 kinase axis defines the signaling, differentiation, and metabolism of T helper 1 and follicular B helper T cells","volume":"43","author":"Ray","year":"2015","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.bbagen.2026.131009_bb0485","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.immuni.2025.06.010","article-title":"More TOR: the expanding role of mTOR in regulating immune responses","volume":"58","author":"Patel","year":"2025","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.bbagen.2026.131009_bb0490","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1172\/JCI77746","article-title":"mTORC1 and mTORC2 selectively regulate CD8+ T cell differentiation","volume":"125","author":"Pollizzi","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.bbagen.2026.131009_bb0495","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nri3901","article-title":"Regulation of innate immune cell function by mTOR","volume":"15","author":"Weichhart","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.bbagen.2026.131009_bb0500","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.it.2016.08.009","article-title":"mTOR-mediated regulation of dendritic cell differentiation and function","volume":"37","author":"Sukhbaatar","year":"2016","journal-title":"Trends Immunol."},{"issue":"4","key":"10.1016\/j.bbagen.2026.131009_bb0505","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1042\/BST20130032","article-title":"Immune responses of macrophages and dendritic cells regulated by mTOR signalling","volume":"41","author":"Katholnig","year":"2013","journal-title":"Biochem. Soc. Trans."},{"issue":"12","key":"10.1016\/j.bbagen.2026.131009_bb0510","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.3390\/cells8121584","article-title":"Targeting mTOR and metabolism in cancer: lessons and innovations","volume":"8","author":"Magaway","year":"2019","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.bbagen.2026.131009_bb0515","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s11357-020-00274-1","article-title":"Effect of rapamycin on aging and age-related diseases-past and future","volume":"43","author":"Selvarani","year":"2021","journal-title":"Geroscience"},{"issue":"1","key":"10.1016\/j.bbagen.2026.131009_bb0520","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/01.CIR.100.1.67","article-title":"Rapamycin reverses chronic graft vascular disease in a novel cardiac allograft model","volume":"100","author":"Poston","year":"1999","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.bbagen.2026.131009_bb0525","doi-asserted-by":"crossref","DOI":"10.18103\/mra.v11i2.3660","article-title":"Inhibition of the mechanistic targets of rapamycin beyond transplant immunosuppression: a mini-review","volume":"11","author":"Al-Taee","year":"2023","journal-title":"Med. Res. Arch."},{"issue":"1","key":"10.1016\/j.bbagen.2026.131009_bb0530","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1523-1755.2001.00460.x","article-title":"Rapamycin in transplantation: a review of the evidence","volume":"59","author":"Saunders","year":"2001","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbagen.2026.131009_bb0535","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.01520","article-title":"Rapamycin: a bacteria-derived immunosuppressant that has anti-atherosclerotic effects and its clinical application","volume":"9","author":"Liu","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbagen.2026.131009_bb0540","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.yjmcc.2023.10.011","article-title":"Mechanistic target of rapamycin in regulating macrophage function in inflammatory cardiovascular diseases","volume":"186","author":"Mangione","year":"2024","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"2","key":"10.1016\/j.bbagen.2026.131009_bb0545","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2147\/vhrm.2007.3.2.191","article-title":"Sirolimus-eluting coronary stents: a review","volume":"3","author":"Abizaid","year":"2007","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.bbagen.2026.131009_bb0550","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3018190","article-title":"Moderate autophagy inhibits vascular smooth muscle cell senescence to stabilize progressed atherosclerotic plaque via the mTORC1\/ULK1\/ATG13 signal pathway","volume":"2017","author":"Luo","year":"2017","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"3","key":"10.1016\/j.bbagen.2026.131009_bb0555","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.3892\/mmr.2017.7032","article-title":"mTOR signaling promotes foam cell formation and inhibits foam cell egress through suppressing the SIRT1 signaling pathway","volume":"16","author":"Zheng","year":"2017","journal-title":"Mol. Med. Rep."},{"issue":"25","key":"10.1016\/j.bbagen.2026.131009_bb0560","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1016\/j.jacc.2009.08.031","article-title":"Beneficial effects of mammalian target of rapamycin inhibition on left ventricular remodeling after myocardial infarction","volume":"54","author":"Buss","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.bbagen.2026.131009_bb0565","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1042\/BJ20110033","article-title":"S6K inhibition renders cardiac protection against myocardial infarction through PDK1 phosphorylation of Akt","volume":"441","author":"Di","year":"2012","journal-title":"Biochem. J."},{"issue":"4","key":"10.1016\/j.bbagen.2026.131009_bb0570","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1634\/theoncologist.2009-0178","article-title":"FDA approval summary: temsirolimus as treatment for advanced renal cell carcinoma","volume":"15","author":"Kwitkowski","year":"2010","journal-title":"Oncologist"},{"issue":"22","key":"10.1016\/j.bbagen.2026.131009_bb0575","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa066838","article-title":"Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma","volume":"356","author":"Hudes","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"9637","key":"10.1016\/j.bbagen.2026.131009_bb0580","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0140-6736(08)61039-9","article-title":"Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial","volume":"372","author":"Motzer","year":"2008","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.bbagen.2026.131009_bb0585","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1109653","article-title":"Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer","volume":"366","author":"Baselga","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbagen.2026.131009_bb0590","doi-asserted-by":"crossref","first-page":"342","DOI":"10.18632\/oncotarget.28410","article-title":"Cancer prevention with rapamycin","volume":"14","author":"Blagosklonny","year":"2023","journal-title":"Oncotarget"},{"issue":"10022","key":"10.1016\/j.bbagen.2026.131009_bb0595","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S0140-6736(15)00817-X","article-title":"Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study","volume":"387","author":"Yao","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bbagen.2026.131009_bb0600","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3390\/cancers10010023","article-title":"mTOR cross-talk in cancer and potential for combination therapy","volume":"10","author":"Conciatori","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.bbagen.2026.131009_bb0605","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-019-0754-1","article-title":"Targeting mTOR for cancer therapy","volume":"12","author":"Hua","year":"2019","journal-title":"J. Hematol. Oncol."},{"issue":"7","key":"10.1016\/j.bbagen.2026.131009_bb0610","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.70167","article-title":"Targeting mTOR kinase for cancer treatment: a comprehensive review with clinical insights","volume":"86","author":"Hossain","year":"2025","journal-title":"Drug Dev. Res."},{"issue":"8","key":"10.1016\/j.bbagen.2026.131009_bb0615","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrn3068","article-title":"Fighting neurodegeneration with rapamycin: mechanistic insights","volume":"12","author":"Bov\u00e9","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"issue":"4","key":"10.1016\/j.bbagen.2026.131009_bb0620","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14463","article-title":"mTOR signaling and Alzheimer\u2019s disease: what we know and where we are?","volume":"30","author":"Davoody","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.bbagen.2026.131009_bb0625","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.2147\/CIA.S429440","article-title":"Rapamycin responds to Alzheimer\u2019s disease: a potential translational therapy","volume":"18","author":"Hou","year":"2023","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.bbagen.2026.131009_bb0630","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.exger.2014.12.002","article-title":"How longevity research can lead to therapies for Alzheimer\u2019s disease: the rapamycin story","volume":"68","author":"Richardson","year":"2015","journal-title":"Exp. Gerontol."},{"issue":"4","key":"10.1016\/j.bbagen.2026.131009_bb0635","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009979","article-title":"Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer\u2019s disease","volume":"5","author":"Spilman","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bbagen.2026.131009_bb0640","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/0271678X15621575","article-title":"Rapamycin rescues vascular, metabolic and learning deficits in apolipoprotein E4 transgenic mice with pre-symptomatic Alzheimer\u2019s disease","volume":"37","author":"Lin","year":"2017","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.bbagen.2026.131009_bb0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104834","article-title":"APOE genotype-dependent pharmacogenetic responses to rapamycin for preventing Alzheimer\u2019s disease","volume":"139","author":"Lin","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbagen.2026.131009_bb0650","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2025.110504","article-title":"Rapamycin exerts neuroprotective effects by inhibiting FKBP12 instead of mTORC1 in the mouse model of Parkinson\u2019s disease","volume":"275","author":"Zhang","year":"2025","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.bbagen.2026.131009_bb0655","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/ng1362","article-title":"Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease","volume":"36","author":"Ravikumar","year":"2004","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.bbagen.2026.131009_bb0660","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/hmg\/ddi458","article-title":"Rapamycin alleviates toxicity of different aggregate-prone proteins","volume":"15","author":"Berger","year":"2006","journal-title":"Hum. Mol. Genet."},{"issue":"4","key":"10.1016\/j.bbagen.2026.131009_bb0665","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1124\/mol.107.043398","article-title":"Rapamycin inhibits polyglutamine aggregation independently of autophagy by reducing protein synthesis","volume":"73","author":"King","year":"2008","journal-title":"Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.bbagen.2026.131009_bb0670","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1016\/S2666-7568(23)00258-1","article-title":"Targeting ageing with rapamycin and its derivatives in humans: a systematic review","volume":"5","author":"Lee","year":"2024","journal-title":"Lancet Healthy Longev."},{"issue":"6967","key":"10.1016\/j.bbagen.2026.131009_bb0675","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/426620a","article-title":"Genetics: influence of TOR kinase on lifespan in C. Elegans","volume":"426","author":"Vellai","year":"2003","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.bbagen.2026.131009_bb0680","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.cub.2004.03.059","article-title":"Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway","volume":"14","author":"Kapahi","year":"2004","journal-title":"Curr. Biol."},{"issue":"5751","key":"10.1016\/j.bbagen.2026.131009_bb0685","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1126\/science.1115535","article-title":"Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients","volume":"310","author":"Kaeberlein","year":"2005","journal-title":"Science"},{"issue":"7253","key":"10.1016\/j.bbagen.2026.131009_bb0690","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nature08221","article-title":"Rapamycin fed late in life extends lifespan in genetically heterogeneous mice","volume":"460","author":"Harrison","year":"2009","journal-title":"Nature"},{"issue":"5949","key":"10.1016\/j.bbagen.2026.131009_bb0695","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1126\/science.1177221","article-title":"Ribosomal protein S6 kinase 1 signaling regulates mammalian life span","volume":"326","author":"Selman","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.bbagen.2026.131009_bb0700","article-title":"Hormetic alteration of mTOR\u2013mitochondria association: an approach to mitigate cellular aging","volume":"29","author":"Mahalakshmi","year":"2022","journal-title":"Curr. Opin. Environ. Sci. Health"},{"key":"10.1016\/j.bbagen.2026.131009_bb0705","doi-asserted-by":"crossref","DOI":"10.5114\/aoms\/191565","article-title":"Impact of rapamycin on longevity: updated insights","author":"Sanati","year":"2024","journal-title":"Arch. Med. Sci."},{"issue":"2","key":"10.1016\/j.bbagen.2026.131009_bb0710","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/gerona\/glq178","article-title":"Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice","volume":"66","author":"Miller","year":"2011","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"1","key":"10.1016\/j.bbagen.2026.131009_bb0715","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083988","article-title":"Mice fed rapamycin have an increase in lifespan associated with major changes in the liver transcriptome","volume":"9","author":"Fok","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.bbagen.2026.131009_bb0720","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/j.molcel.2021.03.018","article-title":"Physiological hypoxia restrains the senescence-associated secretory phenotype via AMPK-mediated mTOR suppression","volume":"81","author":"van Vliet","year":"2021","journal-title":"Mol. Cell"},{"issue":"8","key":"10.1016\/j.bbagen.2026.131009_bb0725","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/ncb3195","article-title":"MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation","volume":"17","author":"Laberge","year":"2015","journal-title":"Nat. Cell Biol."},{"issue":"9","key":"10.1016\/j.bbagen.2026.131009_bb0730","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/ncb3225","article-title":"mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype","volume":"17","author":"Herranz","year":"2015","journal-title":"Nat. Cell Biol."},{"issue":"98","key":"10.1016\/j.bbagen.2026.131009_bb0735","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2000559","article-title":"mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells","volume":"2","author":"Chen","year":"2009","journal-title":"Sci. Signal."},{"issue":"3","key":"10.1016\/j.bbagen.2026.131009_bb0740","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1172\/JCI64099","article-title":"Rapalogs and mTOR inhibitors as anti-aging therapeutics","volume":"123","author":"Lamming","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"21","key":"10.1016\/j.bbagen.2026.131009_bb0745","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.2174\/1568026615666150610125856","article-title":"Age-related neurodegeneration prevention through mTOR inhibition: potential mechanisms and remaining questions","volume":"15","author":"Jahrling","year":"2015","journal-title":"Curr. Top. Med. Chem."},{"issue":"7","key":"10.1016\/j.bbagen.2026.131009_bb0750","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/gerona\/glw090","article-title":"Rapamycin: an inhibitor of aging emerges from the soil of Easter Island","volume":"71","author":"Apelo","year":"2016","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"1","key":"10.1016\/j.bbagen.2026.131009_bb0755","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s40643-022-00554-y","article-title":"Rapamycin golden jubilee and still the miraculous drug: a potent immunosuppressant, antitumor, rejuvenative agent, and potential contributor in COVID-19 treatment","volume":"9","author":"Mohamed","year":"2022","journal-title":"Bioresour. Bioprocess."},{"issue":"5","key":"10.1016\/j.bbagen.2026.131009_bb0760","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1111\/bcp.12893","article-title":"New perspectives on mTOR inhibitors (rapamycin, rapalogs and TORKinibs) in transplantation","volume":"82","author":"Waldner","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"9","key":"10.1016\/j.bbagen.2026.131009_bb0765","doi-asserted-by":"crossref","first-page":"742","DOI":"10.18632\/aging.100688","article-title":"Rapamycin-induced metabolic defects are reversible in both lean and obese mice","volume":"6","author":"Liu","year":"2014","journal-title":"Aging (Albany NY)"},{"issue":"6","key":"10.1016\/j.bbagen.2026.131009_bb0770","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1159\/000528985","article-title":"Why is rapamycin not a Rapalog?","volume":"69","author":"Kuerec","year":"2023","journal-title":"Gerontology"},{"issue":"7\u20138","key":"10.1016\/j.bbagen.2026.131009_bb0775","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.drudis.2011.02.008","article-title":"Targeting the mTOR kinase domain: the second generation of mTOR inhibitors","volume":"16","author":"Zhang","year":"2011","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bbagen.2026.131009_bb0780","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118046","article-title":"Recent advances of the mechanistic target of rapamycin (mTOR) inhibitors for drug discovery","volume":"298","author":"Ni","year":"2025","journal-title":"Eur. J. Med. Chem."},{"issue":"12","key":"10.1016\/j.bbagen.2026.131009_bb0785","doi-asserted-by":"crossref","first-page":"8023","DOI":"10.1074\/jbc.M900301200","article-title":"An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1","volume":"284","author":"Thoreen","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.bbagen.2026.131009_bb0790","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1158\/0008-5472.CAN-12-1702","article-title":"Characterization of Torin2, an ATP-competitive inhibitor of mTOR, ATM, and ATR","volume":"73","author":"Liu","year":"2013","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bbagen.2026.131009_bb0795","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1158\/0008-5472.CAN-09-1751","article-title":"AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity","volume":"70","author":"Chresta","year":"2010","journal-title":"Cancer Res."}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416526001091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416526001091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T09:29:04Z","timestamp":1793870944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304416526001091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":159,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S0304416526001091"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2026.131009","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rapamycin across biology and medicine: From molecular mechanisms to clinical and translational frontiers","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - General Subjects","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbagen.2026.131009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"131009"}}